TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biopart AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
323
|
260
|
573 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-200
|
-315
|
60 |
| EBITDA |
-202
|
-317
|
60 |
| Total assets |
799
|
1,097
|
1,708 |
| Current assets |
799
|
1,097
|
1,708 |
| Current liabilities |
308
|
406
|
92 |
| Equity capital |
491
|
691
|
1,554 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.5%
|
63.0%
|
91.0% |
| Turnover per employee |
323
|
260
|
573 |
| Profit as a percentage of turnover |
-61.9%
|
-121.2%
|
10.5% |
| Return on assets (ROA) |
-25.0%
|
-28.7%
|
3.5% |
| Current ratio |
259.4%
|
270.2%
|
1856.5% |
| Return on equity (ROE) |
-40.7%
|
-45.6%
|
3.9% |
| Change turnover |
63
|
-313
|
-2,964 |
| Change turnover % |
24%
|
-55%
|
-84% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.